Synonyms: Sulfadiazine; Sulfadiazine, Zinc; Sulfadiazin; UNII-0N7609K889; A-306; N(sup1)-2-Pyrimidinylsulfanilamide; EINECS 200-685-8; NSC 35600; 4-amino-N-(pyrimidin-2-yl)benzene-1-sulfonamide; CHEMBL439; N1-2-Pyrimidylsulfanilamide; BRN 0235192; C10H10N4O2S; Sulfazine; Triple sulfa; 4-Amino-N-2-pyrimidinyl-benzenesulfonamide; AI3-01047; S. N. 112; SEEPANYCNGTZFQ-UHFFFAOYSA-N; N(1)-(2-Pyrimidinyl)sulfanilamide; NSC35600; CAS-68-35-9; NCGC00016305-01; Solfadiazina; Sulfadiazene; 0N7609K889; [(4-aminophenyl)sulfonyl]pyrimidin-2-ylamine; NSC117870; Pecta-Diazine; SMR000059113; Sulfadiazine (TN); N-(2-Pyrimidinyl)sulfanilamide; Sulfadiazine [USAN:INN:JAN]; rBPI21 & Sulfa; SR-01000002973; Liquadiazine; SSD; 2-Sulfanilamido-pyrimidine; CRL-8131 & Sulfadiazine; Sulfadiazine (JAN/USP/INN); Sulfadiazine,(S); Trisulfapyrimidine, oral suspension; Sulfadiazine [USP:INN:BAN:JAN]; DRG-0214; Prestwick_428; Spectrum_000986; Sulfapyrimidin; Sulfadiazina Reig Jofre; Sulfacombin (Salt/Mix); AC1L1JUR; Prestwick0_000023; Prestwick1_000023; Prestwick2_000023; Prestwick3_000023; Spectrum2_001319; Spectrum3_001362; Spectrum4_000342; Adiazin; Spectrum5_000992; Epitope ID:140083; AC1Q51XM; AC1Q6W1E; Sulfadiazine, >=99.0%; DSSTox_CID_24130; DSSTox_RID_80105; DSSTox_GSID_44130; Oprea1_081078; SCHEMBL24176; Adiazine; BSPBio_000085; BSPBio_002884; KBioGR_000743; KBioSS_001466; 5-25-10-00067 (Beilstein Handbook Reference); MLS000069423; MLS006011457; DivK1c_000543; SPECTRUM1500546; SPBio_001417; Debenal; SPBio_002006; BPBio1_000095; WLN: T6N CNJ BMSWR DZ; DTXSID7044130; CTK7D7930; HMS501L05; KBio1_000543; KBio2_001466; KBio2_004034; KBio2_006602; Pyrimal; KBio3_002104; NINDS_000543; HMS1568E07; HMS1921A13; HMS2090P09; HMS2092I15; HMS2095E07; HMS2235D19; HMS3371L19; HMS3655I10; 2-Sulfanilamidopyrimidine; HMS3712E07; Pharmakon1600-01500546; ZINC120319; ALBB-014888; BCP12140; HY-B0273; Tox21_110360; BBL013169; BDBM50166571; CCG-39257; Sulfazin; Cremodiazine; NSC-35600; NSC757324; Recombinant bactericidal/permeability-increasing protein & Sulfadiazine; s1770; SBB007604; SBB057674; STK317797; 2-(p-Aminobenzenesulfonamido)pyrimidin; AKOS000119073; CS-2263; Spofadrizine; DB00359; KS-1144; MCULE-4577338719; NE10425; NSC-757324; RP17586; 2-(4-Aminobenzenesulfonamido)pyrimidine; 4-amino-N-2-pyrimidylbenzenesulfonamide; IDI1_000543; N1-2(1H)-pyrimidinylidene-sulfanilamide; Theradiazine; NCGC00016305-02; NCGC00016305-03; NCGC00016305-04; NCGC00016305-05; NCGC00016305-06; NCGC00016305-10; NCGC00023291-03; NCGC00023291-04; SULFADIAZINE (TRISULFAPYRIMIDINES); 2-(4-Aminobenzenesulfonylamino)pyrimidine; Cremotres; AC-26817; AK321973; H458; ST059447; Sulfanilamide, N1-2-pyrimidinyl- (8CI); ZB004097; Mixture of sulfadiazine, and sulfamethazine; SBI-0051520.P003; AB2000282; LS-147838; Deltazina; 4-[[(Pyrimidin-2-yl)amino]sulfonyl]aniline; 4-Amino-N-2-pyrimidinyl- benzenesulfonamide; AB00052095; Benzenesulfonamide,4-amino-N-2-pyrimidinyl-; FT-0674741; R3929; S0579; ST51006797; SW196657-3; TL80073596; Diazolone; 4-amino-N-(2-pyrimidinyl) benzenesulfonamide; 4-Amino-n-(2-pyrimidinyl)benzene-sulfonamide; 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide #; 68S359; C07658; D00587; Trisulfapyrimidine, oral suspension (Salt/Mix); AB00052095-13; AB00052095-14; AB00052095_15; Eskadiazine; AB00052095_16; Benzenesulfonamide, 4-amino-N-(2-pyrimidinyl)-; Sulfadiazine, VETRANAL(TM), analytical standard; Q-201759; SR-01000002973-2; SR-01000002973-3; BRD-K32273377-001-05-4; BRD-K32273377-001-09-6; I01-15838; F1657-1720; Microsulfon; I14-110269; Sulfadiazine, certified reference material, TraceCERT(R); Z271004844; Sulfadiazine, European Pharmacopoeia (EP) Reference Standard; Sulfadiazine, United States Pharmacopeia (USP) Reference Standard; Sulfadiazine, Pharmaceutical Secondary Standard; Certified Reference Material; 141582-64-1; Sulfadiazine for identification of impurity F, European Pharmacopoeia (EP) Reference Standard; Sulfazin; Sulfacombin; Neotrizine; Soludiazine; Lantrisul; Sulfaloid; Suthogen; sulfadiazin-; Sulfonamide Duplex; Triple Sulfoid; Diazyl (VAN); Mixture Name; Sodium sulfadiazine; Palatrize; Sulfadiazine, Zinc; Neotrizine (TN); Solfadiazina sodica; Sulfadiazin-natrium; Sulfadiazina sodica; Lantrisul (TN); Sulfaloid (TN); Sulfa-Triple #2; Terfonyl (TN); Soluble sulfadiazine; Sulfazine; Piridisir; Sulfadiazine sodique; Sulfose (TN); Sodium sulfapyrimidine; Sulfadiazinum natricum; Triple Sulfa (TN); Triple Sulfas (TN); Triple Sulfoid (TN); 2-Sulfanilamidopyridine; SULFADIAZINE SODIUM; Sulfonamides Duplex (TN); Quadetts; Sulfa-Triple #2 (TN); D05LKP; Solfadiazina sodica [DCIT]; C10H10N4O2S.Na; UNII-84CS1P306F; component of Sulfonamide Duplex; Sulfonamide Duplex (Salt/Mix); Sulfadiazine sodium [USP:INN]; Sulfadiazine sodium [USAN:INN]; CID5215; Quadramoid; Sulfadiazina sodica [INN-Spanish]; Sulfadiazine sodique [INN-French]; Monosodium 2-sulfanilamidopyrimidine; Sulfadiazinum natricum [INN-Latin]; C10-H10-N4-O2-S.Na; EINECS 208-919-0; 2-Sulfanilamidopyrimidine sodium salt; AN-160; AR-1L4215; C10-H10-N4-O2-S; Sanodiazine; CS-O-02298; NSC 117870; Sulfadiazine, 99% - 100G 100g; Sulfanilamide, N1-2-pyrimidinyl-(8CI); A8527; Bencenosulfonamida, 4-amino-n-2-pirimidinil-; N1-2-Pyrimidinylsulfanilamide monosodium salt; Sodium, (N(sup 1)-2-pyrimidinylsulfanilamido)-; D013411; N(sup 1)-2-Pyrimidinylsulfanilamide monosodium salt; Sterazine; SDA; Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosodium salt; Mixture of sulfadiazine, sulfamerazine, and sulfamethazine; Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosodium salt; Adiazin;Adiazine;Debenal;Liquadiazine;Microsulfon;Sulfazine;Sulfolex; Bencenosulfonamida, 4-amino-N-2-pirimidinil-, sal de sodio (1:1); Sulfanilamide, N(sup 1)-2-pyrimidinyl-, N(sup 1)-sodium deriv; 116-44-9; SDZ; Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine; Sulfatryl; 547-32-0; 6938-59-6; Sulfolex; Sulfonsol; Terfonyl; Trifonamide; Sulphadiazine; Truozine; Diazin; Diazyl; Neazine; Pirimal; Sulfose; Trisem; Sulfanilamidopyrimidine; Honey diazine; Lipo-Levazine; Zinc Sulfadiazine; Tri-Sulfameth; Triple Sulfas; Coco-Diazine; Lipo-Diazine; Metha-Meridiazine; Sulfadiazinum; Diazovit; Sulfadiazina; Sulphadiazine E; Sulfapirimidin; sulfadiazine; Di-Azo-Mul; Thi-Di-Mer; 2-Sulfanilylaminopyrimidine; Codiazine; Silvadene; Pecta-diazine, suspension; Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-; CocoDiazine; Solfadiazina [DCIT]; RP 2616; Sulphadiazine; 4-amino-N-(pyrimidin-2-yl)benzenesulfonamide; Pyrimidine, 2-sulfanilamido-; 2-Sulfanilamidopyrimidin; Sulfapyrimidin [German]; 2-Sulfapyrimidine; Sulfonamides Duplex; Sulfadiazinum [INN-Latin]; Sulfadiazina [INN-Spanish]; 4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE; Zinc Sulfadiazine; 68-35-9; N(1)-2-pyrimidylsulfanilamide; N(1)-2-pyrimidinylsulfanilamide; 2-Sulfanilamidopyrimidin [German]; S.N. 112; 4-amino-N-pyrimidin-2-ylbenzenesulfonamide; A 306; A-306 (VAN); N(sup 1)-2-Pyrimidinylsulfanilamide; MFCD00006065; Thermazene; Sulfapyrimidine; N1-2-Pyrimidinylsulfanilamide; Sildaflo; CHEBI:9328; Sulfanilamide, N(sup 1)-2-pyrimidinyl-; N(sup1)-2-Pyrimidylsulfanilamide; Sulfanilamide, N1-2(1H)-pyrimidinylidene-; 4-Amino-N-(2-pyrimidinyl)benzenesulfonamide; 4-amino-N-pyrimidin-2-yl-benzenesulfonamide; N1-(Pyrimidin-2-yl)sulfanilamide; Sulfanilamide, N1-2-pyrimidinyl-;